Creatine is breaking out of the gym and stepping into clinical neuroscience. With early research pointing to cognitive benefits in Alzheimer’s patients, its potential is impossible to ignore.

The first-ever blood test to detect Alzheimer’s disease has been cleared by the U.S. Food and Drug Administration (FDA). In a Friday press release, the agency announced its approval of the first ...

Joe Walsh, 79, is waiting to inhale. He's perched on a tan recliner at the Center for Alzheimer Research and Treatment at Brigham and Women's Hospital in Boston. His wife, Karen Walsh, hovers over ...

The F.D.A., and Alzheimer’s experts, emphasized that the blood test should be given only to people who are already experiencing cognitive decline and are ages 55 and older.

A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for repurposing in dementia prevention.

New data reveals more than 7 million Americans are currently living with Alzheimer’s – a first in U.S. history. Experts warn this number is projected to nearly double, reaching an estimated 14 ...

The FDA's sign-off on marketing for Fujirebio's test comes years after other blood tests for Alzheimer's have already begun sales, without this kind of approval from the agency.

June 6 is Men's Day at One Senior Place in Viera. Hang with the guys for a few hours with an RSVP to oneseniorplace.com or by calling 321-751-6771.. Brenda Lyle is a certified care manager and ...

People who follow a MIND diet, even if started later in life, were significantly less likely to develop Alzheimer's disease or related forms of dementia, according to new research.

June is Alzheimer's and Brain Awareness Month. More than 7 million Americans ages 65 and older are living with Alzheimer’s disease right now.

7News spoke with a neurologist about the connection between creatine and Alzheimer’s patients. Fri, 27 Jun 2025 16:11:25 GMT (1751040685202) Story Infinite Scroll ...

This couple is helping scientists find out Researchers think an experimental anti-inflammatory drug for people with multiple sclerosis might help Alzheimer's patients. And they've already tried it ...